Vanguard Group
EDSA icon

Vanguard Group’s Edesa Biotech EDSA Stock Holding History

Vanguard Group’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$54.5K Sell
37,600
-7,943
-17% -$15.6K ﹤0.01% 4233
2025
Q3 		$111K Buy
45,543
+29,679
+187% +$68.6K ﹤0.01% 4215
2025
Q2 		$32K Hold
15,864
– – ﹤0.01% 4222
2025
Q1 		$38.7K Hold
15,864
– – ﹤0.01% 4209
2024
Q4 		$27K Hold
15,864
– – ﹤0.01% 4245
2024
Q3 		$70.6K Hold
15,864
– – ﹤0.01% 4225
2024
Q2 		$67.9K Hold
15,864
– – ﹤0.01% 4265
2024
Q1 		$66.5K Sell
15,864
-481
-3% -$2.24K ﹤0.01% 4282
2023
Q4 		$74.7K Buy
16,345
+508
+3% +$1.93K ﹤0.01% 4338
2023
Q3 		$70.1K Sell
15,837
-3
-0% -$18 ﹤0.01% 4377
2023
Q2 		$89.9K Hold
15,840
– – ﹤0.01% 4401
2023
Q1 		$101K Hold
15,840
– – ﹤0.01% 4404
2022
Q4 		$240K Buy
15,840
+24
+0.2% +$179 ﹤0.01% 4273
2022
Q3 		$102K Hold
15,816
– – ﹤0.01% 4491
2022
Q2 		$178K Hold
15,816
– – ﹤0.01% 4484
2022
Q1 		$329K Hold
15,816
– – ﹤0.01% 4459
2021
Q4 		$623K Sell
15,816
-74
-0.5% -$3.54K ﹤0.01% 4383
2021
Q3 		$821K Buy
15,890
+296
+2% +$11.5K ﹤0.01% 4290
2021
Q2 		$576K Buy
15,594
+7,338
+89% +$297K ﹤0.01% 4247
2021
Q1 		$312K Buy
8,256
+5,546
+205% +$223K ﹤0.01% 4203
2020
Q4 		$81K Buy
2,710
+1,114
+70% +$45.5K ﹤0.01% 4155
2020
Q3 		$90K Buy
+1,596
New +$75.9K ﹤0.01% 4026

Other funds holding EDSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return

Vanguard Group's EDSA Position: Q4 2025 in Review

Vanguard Group reduced its Edesa Biotech (EDSA) stake by 17% in Q4 2025, selling an estimated $15.6K and leaving 37,600 shares worth $54.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4233.

Vanguard Group first reported a position in EDSA in Q3 2020 and has held it in 22 quarters since. The position peaked at $821K in Q3 2021. 22 funds tracked by Wall St. Rank hold EDSA as of Q4 2025.

  • Vanguard Group held 37,600 shares of Edesa Biotech worth $54.5K as of Q4 2025.
  • Vanguard Group sold 7,943 Edesa Biotech shares in Q4 2025, an estimated $15.6K.
  • Edesa Biotech made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4233 holding.
  • Vanguard Group first reported a position in Edesa Biotech in Q3 2020 and has held it in 22 quarters since.
  • Vanguard Group's Edesa Biotech position peaked at $821K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.